Silvant Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,237	Closed	-$1.74M	–	339
2020 Q3	$1.74M	Sell	15,237 -4,095	-21%	-$442K	0.33%	78
2020 Q2	$2.17M	Sell	19,332 -1,298	-6%	-$138K	0.39%	72
2020 Q1	$1.85M	Sell	20,630 -404	-2%	-$39.6K	0.4%	70
2019 Q4	$2.27M	Sell	21,034 -323	-2%	-$34.5K	0.41%	72
2019 Q3	$2.09M	Sell	21,357 -2,716	-11%	-$306K	0.41%	68
2019 Q2	$3.15M	Sell	24,073 -2,251	-9%	-$290K	0.56%	54
2019 Q1	$3.56M	Sell	26,324 -1,078	-4%	-$134K	0.64%	48
2018 Q4	$2.67M	Sell	27,402 -795	-3%	-$94K	0.53%	59
2018 Q3	$3.92M	Sell	28,197 -4,481	-14%	-$562K	0.48%	76
2018 Q2	$4.06M	Sell	32,678 -376	-1%	-$43.9K	0.5%	75
2018 Q1	$3.68M	Buy	+33,054	New	+$3.95M	0.47%	78